309 related articles for article (PubMed ID: 15253956)
21. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
[TBL] [Abstract][Full Text] [Related]
22. Testosterone replacement therapy improves QTaVI in hypogonadal men with spinal cord injury.
La Fountaine MF; Wecht JM; Cirnigliaro CM; Kirshblum SC; Spungen AM; Bauman WA
Neuroendocrinology; 2013; 97(4):341-6. PubMed ID: 23343764
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
24. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
25. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
26. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
27. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
Blick G; Khera M; Bhattacharya RK; Nguyen D; Kushner H; Miner MM
Pain Med; 2012 May; 13(5):688-98. PubMed ID: 22536837
[TBL] [Abstract][Full Text] [Related]
28. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
[TBL] [Abstract][Full Text] [Related]
29. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
[TBL] [Abstract][Full Text] [Related]
30. Testosterone concentrations in hair of hypogonadal men with and without testosterone replacement therapy.
Thomson S; Koren G; Van Steen V; Rieder M; Van Uum SH
Ther Drug Monit; 2009 Dec; 31(6):779-82. PubMed ID: 19809386
[TBL] [Abstract][Full Text] [Related]
31. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
32. The effects of pharmacologically induced hypogonadism on mood in healthy men.
Schmidt PJ; Berlin KL; Danaceau MA; Neeren A; Haq NA; Roca CA; Rubinow DR
Arch Gen Psychiatry; 2004 Oct; 61(10):997-1004. PubMed ID: 15466673
[TBL] [Abstract][Full Text] [Related]
33. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
[TBL] [Abstract][Full Text] [Related]
34. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
[TBL] [Abstract][Full Text] [Related]
35. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
36. [Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].
Asscheman H; Gooren LJ
Ned Tijdschr Geneeskd; 2000 Apr; 144(18):847-50. PubMed ID: 10816775
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men.
Wang C; Ilani N; Arver S; McLachlan RI; Soulis T; Watkinson A
Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131
[TBL] [Abstract][Full Text] [Related]
38. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study.
English KM; Steeds RP; Jones TH; Diver MJ; Channer KS
Circulation; 2000 Oct; 102(16):1906-11. PubMed ID: 11034937
[TBL] [Abstract][Full Text] [Related]
39. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
[TBL] [Abstract][Full Text] [Related]
40. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]